M V Martin

2.1k total citations · 1 hit paper
16 papers, 1.8k citations indexed

About

M V Martin is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, M V Martin has authored 16 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in M V Martin's work include Pharmacogenetics and Drug Metabolism (12 papers), Metabolomics and Mass Spectrometry Studies (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). M V Martin is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Metabolomics and Mass Spectrometry Studies (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). M V Martin collaborates with scholars based in United States, Australia and France. M V Martin's co-authors include F. Peter Guengerich, David J. Waxman, T. Wolff, Philippe Beaune, P. Kremers, Linda M. Distlerath, P.E.B. Reilly, Zhimou Guo, G. Wilkinson and John R. Falck and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Lipid Research and Archives of Biochemistry and Biophysics.

In The Last Decade

M V Martin

16 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism.

1986 668 citations F. Peter Guengerich, M V Martin et al. Journal of Biological Chemistry profile →

Peers

M V Martin

PHARM

ONCOL

BIOCH

EDM

Mitsukazu Kitada Japan

F. Peter Guengerich United States

Maurice E. Veronese Australia

Sang S. Park United States

T. Kamataki Japan

Y. Yasukochi Japan

P. Kremers Belgium

Linda C. Quattrochi United States

Frederick J. Di Carlo United States

M J Coon United States

Mitsukazu Kitada Japan

M V Martin

1.3k ×0.9

PHARM

555 ×0.8

ONCOL

588 ×1.1

190 ×0.6

BIOCH

197 ×1.0

EDM

Citations per year, relative to M V Martin M V Martin (= 1×) peers Mitsukazu Kitada

Countries citing papers authored by M V Martin

Since Specialization

Citations

This map shows the geographic impact of M V Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M V Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M V Martin more than expected).

Fields of papers citing papers by M V Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M V Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M V Martin. The network helps show where M V Martin may publish in the future.

Co-authorship network of co-authors of M V Martin

This figure shows the co-authorship network connecting the top 25 collaborators of M V Martin. A scholar is included among the top collaborators of M V Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M V Martin. M V Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Gillam, Elizabeth M. J., Zhimou Guo, M V Martin, Christopher M. Jenkins, & F. Peter Guengerich. (1995). Expression of Cytochrome P450 2D6 in Escherichia coli, Purification, and Spectral and Catalytic Characterization. Archives of Biochemistry and Biophysics. 319(2). 540–550. 90 indexed citations

Guengerich, F. Peter, W. Griffith Humphreys, Chul‐Ho Yun, et al.. (1995). Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues.. PubMed. 23. 78–84. 20 indexed citations

Sandhu, Punam, Zhimou Guo, T. Baba, et al.. (1994). Expression of Modified Human Cytochrome P450 1A2 in Escherichia coli: Stabilization, Purification, Spectral Characterization, and Catalytic Activities of the Enzyme. Archives of Biochemistry and Biophysics. 309(1). 168–177. 168 indexed citations

Guengerich, F. Peter, et al.. (1992). Catalytic mechanisms of amine-N-dealkylation and N-oxygenation by cytochrome P450 enzymes. Journal of Basic and Clinical Physiology and Pharmacology. 3(Supplement). 102–103. 1 indexed citations

Voigt, Jeffrey M., et al.. (1990). In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats.. Molecular Pharmacology. 37(2). 182–191. 29 indexed citations

Falck, John R., Sun Lumin, Ian A. Blair, et al.. (1990). Cytochrome P-450-dependent oxidation of arachidonic acid to 16-, 17-, and 18-hydroxyeicosatetraenoic acids.. Journal of Biological Chemistry. 265(18). 10244–10249. 84 indexed citations

Capdevila, Jorge H., et al.. (1990). Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase.. Journal of Biological Chemistry. 265(19). 10865–10871. 123 indexed citations

Emmons, Gary T, Jan St. Pyrek, R. Michael van Dam, et al.. (1988). 5 alpha-cholest-8(14)-en-3 beta-ol-15-one, a potent regulator of cholesterol metabolism: occurrence in rat skin.. Journal of Lipid Research. 29(8). 1039–1054. 14 indexed citations

Khan, Sumsullah, M V Martin, Anver D. Rahimtula, & J. F. Payne. (1987). Effect of a Prudhoe Bay crude oil on hepatic and placental drug metabolism in rats. Canadian Journal of Physiology and Pharmacology. 65(12). 2400–2408. 7 indexed citations

10.

Guengerich, F. Peter, Diane R. Umbenhauer, Perry F. Churchill, et al.. (1987). Polymorphism of human cytochrome P-450. Xenobiotica. 17(3). 311–316. 26 indexed citations

11.

Guengerich, F. Peter, Linda M. Distlerath, P.E.B. Reilly, et al.. (1986). Human-liver cytochromes P-450 involved in polymorphisms of drug oxidation. Xenobiotica. 16(5). 367–378. 60 indexed citations

12.

Guengerich, F. Peter, M V Martin, Philippe Beaune, et al.. (1986). Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism.. Journal of Biological Chemistry. 261(11). 5051–5060. 668 indexed citations breakdown →

13.

Distlerath, Linda M., et al.. (1985). Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.. Journal of Biological Chemistry. 260(15). 9057–9067. 278 indexed citations

14.

Wolff, T., Linda M. Distlerath, Mark Worthington, et al.. (1985). Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling.. PubMed. 45(5). 2116–22. 104 indexed citations

15.

Guengerich, F. Peter, Ghazi A. Dannan, Stephen Wright, M V Martin, & Laurence S. Kaminsky. (1982). Purification and characterization of microsomal cytochrome P-450s. Xenobiotica. 12(11). 701–716. 146 indexed citations

16.

Martin, M V, et al.. (1981). Separation by counter-current distribution of rat and chicken erythrocytes of different age, and its application to the assay of enzyme activities.. PubMed. 40(7-8). 979–84. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact